2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Bio Sidus SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease Recombinant human alpha galactosidase A (agalsidase beta), Recombinant human alpha-galactosidase A (agalsidase beta) - Fabry Disease | Phase 3 | Completed | Bio Sidus SA | 20 | 2022-12-13 | 2026-02-18 |
| Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease Erythropoietin alfa - Anemia of Chronic Kidney Disease | Phase 3 | Completed | Bio Sidus SA | 43 | 2018-02-28 | 2025-03-20 |
Anemia (1) · Fabry Disease (1) · Renal Insufficiency, Chronic (1)
agalsidase beta (1)
Argentina (2) · Paraguay (1)